Children's Hospital Association submitted comments on the cell and gene therapy request for information (RFI) from Sen. Bill Cassidy (R-La.), ranking member of the Senate Health, Education, Labor, and Pensions (HELP) Committee. Our response highlights the need to ensure children’s equitable access to these therapies and a strong national framework for payment and oversight.
CHA Response to Cell and Gene Therapy RFI
Cell and gene therapies have the potential to address unmet pediatric medical needs, reduce the need for costly chronic care, and help address health disparities.
Related Content
Families and Children's Hospitals Urge Congressional Action on Pediatric Health Priorities
Family Advocacy Day brings families to Capitol Hill to highlight growing barriers to care, from Medicaid coverage to workforce shortages and youth mental health.
Where Kids’ Stories Help Guide Policy
Family Advocacy Day empowers children to share their experiences and help shape the future of pediatric care.
CHA Submits Letter on New NPI and Provider-Based Attestation Requirements
The letter emphasizes that the requirements would impose significant administrative, billing, and operational burden on children's hospitals.